HomeTechnology TransferTechnologiesTherapeutic Applications of Interleukin-12 (IL-12)
Technology Transfer

Therapeutic Applications of Interleukin-12 (IL-12)

Inventor(s)

Giorgio Trinchieri and Bice Perussia

Tech ID
TG8829 and SP9487
Key Words
adjuvant., Cancer, immunotherapy, Therapeutic, Vaccine
Applications and Advantages

IL-12, in combination with other agents, may have applications for cancer therapy, immunotherapy and vaccine adjuvant use.

Intellectual Property Status

U.S. Patent Nos. 5,457,038; 5,569,454; 5,571,515; 5,648,072; 5,648,467; 5,723,127; 5,976,539 and 6,168,923; and international patents.

Licensing Opportunity

A non-exclusive license to the technology is available for organizations that are developing products containing one or more IL-12 subunits or a gene expressing an IL-12 subunit.